A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function

Fundamental and Clinical Pharmacology

Volumn 23, Issue 4, 2009, Pages 515-520

  Sweileh, Waleed M ^a  

^a AN NAJAH NATIONAL UNIVERSITY   (Palestine)

Author keywords

Amikacin; Gentamicin; Nephrotoxicity; Renal function

Indexed keywords

AMIKACIN; CREATININE; FUROSEMIDE; GENTAMICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG DOSE COMPARISON; FEMALE; GOVERNMENT; GROUPS BY AGE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PATHOGENESIS; POPULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE DRUG DOSE; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMIKACIN; ANTI-BACTERIAL AGENTS; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENTAMICINS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 68749111844     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00702.x     Document Type: Article

References (22)

1. Drusano G.L., Ambrose P.G., Bhavnani S.M., Bertino J.S., Nafziger A.N., Louie A. Back to the future: using aminoglycosides again and how to dose them optimally. Clin. Infect. Dis. (2007) 45 753 760. Review.
2. Martínez-Salgado C., López-Hernández F.J., López-Novoa J.M. Glomerular nephrotoxicity of aminoglycosides. Toxicol. Appl. Pharmacol. (2007) 223 86 98. Review.
3. Bonadio M., Maccanti O., Giovannini L. et al. Comparative nephrotoxicity and tissue accumulation of dactimicin, amikacin and gentamicin. Drugs Exp. Clin. Res. (1987) 13 747 750.
4. Sairio E., Kasanen A., Kangas L., Nieminen A.L., Nieminen L. The nephrotoxicity and renal accumulation of amikacin, tobramycin and gentamycin in rats, rabbits and guinea pigs. Exp. Pathol. (Jena) (1978) 15 370 375.
5. Provoost A.P., Adejuyigbe O., Wolff E.D. Nephrotoxicity of aminoglycosides in young and adult rats. Pediatr. Res. (1985) 19 1191 1196.
6. French M.A., Cerra F.B., Plaut M.E., Schentag J.J. Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients. Antimicrob. Agents Chemother. (1981) 19 147 152.
7. Smith C.R., Baughman K.L., Edwards C.Q., Rogers J.F., Lietman P.S. Controlled comparison of amikacin and gentamicin. N. Engl. J. Med. (1977) 296 349 353.
8. Lerner S.A., Schmitt B.A., Seligsohn R., Matz G.J. Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. Am. J. Med. (1986) 80 98 104.
9. De Broe M.E., Paulus G.J., Verpooten G.A. et al. Early effects of gentamicin, tobramycin, and amikacin on the human kidney. Kidney Int. (1984) 25 643 652.
10. Chromý V., Rozkosná K., Sedlák P. Determination of serum creatinine by Jaffe method and how to calibrate to eliminate matrix interference problems. Clin. Chem. Lab. Med. (2008) 46 1127 1133.
11. Ballesteros J., Northland R., Wolff M. Gentamicin and amikacin nephrotoxicity: comparative study in patients with initially normal renal function. Rev. Med. Chil. (1989) 117 10 17.
12. Blaser J., Konig C. Once daily dosing of aminoglycosides. Eur. J. Clin. Microbiol. Infect. Dis. (1995) 14 1029 1038.
13. Galloe A.M., Graudal N., Christensen H.R., Kampmann J.P. Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety. Eur. J. Clin. Pharmacol. (1995) 48 39 43.
14. Barza M., Ioannidis J.P.A., Cappelleri J.C., Lau J. Single or multiple daily doses of aminoglycosides: a meta-analysis. Br. Med. J. (1996) 312 338 345. (Pubitemid 26049400)
15. Ferriols-Lisart R., Alos-Alminana M. Effectiveness and safety of once-daily aminoglycosides: a meta-analysis. Am. J. Health Syst. Pharmacol. (1996) 53 1141 1150.
16. Hatala R., Dinh T., Cook D.J. Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann. Intern. Med. (1996) 124 7.
17. Munckhof W.J., Grayson M.L., Tumidge J.D. A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J. Antimicrob. Chemother. (1996) 37 645 663.
18. Ali M.Z., Goetz M.B. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin. Infect. Dis. (1997) 24 796 809.
19. Bailey T.C., Little J.R., Littenberg B., Reichley R.M., Dunagan W.C. A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin. Infect. Dis. (1997) 24 786 795.
20. Hatala R., Dinh T.T., Cook D.J. Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review. Clin. Infect. Dis. (1997) 24 810 815.
21. Nicolau D.P., Freeman C.D., Belliveau P.P. et al. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob. Agents Chemother. (1995) 39 650 655.
22. Nicolau D.P., Wu A.H., Finocchiaro S. et al. Once-daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring. Ther. Drug Monit. (1996) 18 263 266.